Perelló, Joan
Gómez, M.
Ferrer, M. D.
Rodríguez, N. Y.
Salcedo, C.
Buades, J. M.
Pérez, M. M.
Torregrosa, J. V.
Martín, E.
Maduell, F.
Funding for this research was provided by:
Instituto de Salud Carlos III (REDINREN RD012/0021)
Ministerio de Economía y Competitividad (RETOS COLABORACIÓN RTC201424601)
Article History
Received: 11 July 2017
Accepted: 2 November 2017
First Online: 19 January 2018
Compliance with Ethical Standards
:
: MF, CS, MMP and JP are employees or receive honoraria from Laboratoris Sanifit SL. JP is shareholder at Laboratoris Sanifit SL. The remaining authors do not declare any competing financial interests. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.
: The study was conducted in accordance with the guidelines written in the Declaration of Helsinki and all procedures involving human subjects were approved by the Ethical Committee of Clinical Investigation of the Balearic Islands.